MedPath

to check the effect of bilirubin and albumin ratio with duration of phototherapy

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: P84- Other problems with newborn
Registration Number
CTRI/2024/07/070378
Lead Sponsor
Datta Meghe Institute of Higher Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All the Neonates admitted in NICU receiving phototherapy for hyperbilirubinemia after 24 hours of life.

Exclusion Criteria

Neonates with Conjugated Hyperbilirubinemia.

Neonates with co-morbidities like acute renal failure, Hydrops foetalis, congenital nephritic syndrome, and other diseases that mimic BIND as well as death due to other reasons

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
duration of phototherapy significantly correlates to the bilirubin and albumin ratioTimepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath